PMC:3359311 / 17820-18006 JSONTXT

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T7386","span":{"begin":10,"end":15},"obj":"P01584"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}

{"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T5947","span":{"begin":10,"end":15},"obj":"Protein"},{"id":"T5948","span":{"begin":20,"end":29},"obj":"Positive_regulation"},{"id":"T5949","span":{"begin":106,"end":116},"obj":"Gene_expression"},{"id":"T5950","span":{"begin":135,"end":143},"obj":"Regulation"}],"relations":[{"id":"R5112","pred":"themeOf","subj":"T5947","obj":"T5948"},{"id":"R5113","pred":"themeOf","subj":"T5947","obj":"T5949"},{"id":"R5114","pred":"themeOf","subj":"T5949","obj":"T5950"}],"attributes":[{"id":"M120","pred":"Speculation","subj":"T5950","obj":"true"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}

{"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T9156","span":{"begin":10,"end":15},"obj":"Protein"},{"id":"T9157","span":{"begin":20,"end":29},"obj":"Positive_regulation"},{"id":"T9158","span":{"begin":106,"end":116},"obj":"Gene_expression"}],"relations":[{"id":"R7997","pred":"themeOf","subj":"T9156","obj":"T9157"},{"id":"R8000","pred":"themeOf","subj":"T9156","obj":"T9158"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}

{"project":"events-check-again","denotations":[{"id":"T9066","span":{"begin":10,"end":15},"obj":"Protein"},{"id":"T9067","span":{"begin":20,"end":29},"obj":"Positive_regulation"},{"id":"T9068","span":{"begin":106,"end":116},"obj":"Gene_expression"},{"id":"T9069","span":{"begin":135,"end":143},"obj":"Regulation"}],"relations":[{"id":"R7960","pred":"themeOf","subj":"T9066","obj":"T9067"},{"id":"R7964","pred":"themeOf","subj":"T9066","obj":"T9068"},{"id":"R7966","pred":"themeOf","subj":"T9068","obj":"T9069"}],"attributes":[{"id":"M168","pred":"Speculation","subj":"T9069","obj":"true"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}

{"project":"GO-BP","denotations":[{"id":"T8826","span":{"begin":65,"end":73},"obj":"http://purl.obolibrary.org/obo/GO_0007349"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T7430","span":{"begin":0,"end":6},"obj":"NNS"},{"id":"T7431","span":{"begin":7,"end":9},"obj":"IN"},{"id":"T7432","span":{"begin":10,"end":15},"obj":"NN"},{"id":"T7433","span":{"begin":16,"end":19},"obj":"VBP"},{"id":"T7434","span":{"begin":20,"end":29},"obj":"VBN"},{"id":"T7435","span":{"begin":30,"end":32},"obj":"IN"},{"id":"T7436","span":{"begin":33,"end":36},"obj":"DT"},{"id":"T7437","span":{"begin":37,"end":41},"obj":"NNP"},{"id":"T7438","span":{"begin":42,"end":44},"obj":"IN"},{"id":"T7439","span":{"begin":45,"end":47},"obj":"NNP"},{"id":"T7440","span":{"begin":48,"end":56},"obj":"NNS"},{"id":"T7441","span":{"begin":57,"end":60},"obj":"CC"},{"id":"T7442","span":{"begin":61,"end":64},"obj":"DT"},{"id":"T7443","span":{"begin":65,"end":73},"obj":"JJ"},{"id":"T7444","span":{"begin":74,"end":80},"obj":"NN"},{"id":"T7445","span":{"begin":81,"end":83},"obj":"IN"},{"id":"T7446","span":{"begin":84,"end":88},"obj":"DT"},{"id":"T7447","span":{"begin":89,"end":97},"obj":"NN"},{"id":"T7448","span":{"begin":98,"end":101},"obj":"CC"},{"id":"T7449","span":{"begin":102,"end":105},"obj":"PRP$"},{"id":"T7450","span":{"begin":106,"end":116},"obj":"NN"},{"id":"T7451","span":{"begin":117,"end":119},"obj":"IN"},{"id":"T7452","span":{"begin":120,"end":123},"obj":"DT"},{"id":"T7453","span":{"begin":124,"end":131},"obj":"NN"},{"id":"T7454","span":{"begin":132,"end":134},"obj":"IN"},{"id":"T7455","span":{"begin":135,"end":143},"obj":"JJ"},{"id":"T7456","span":{"begin":144,"end":156},"obj":"JJ"},{"id":"T7457","span":{"begin":157,"end":167},"obj":"NN"},{"id":"T7458","span":{"begin":168,"end":171},"obj":"VBP"},{"id":"T7459","span":{"begin":172,"end":177},"obj":"RB"},{"id":"T7460","span":{"begin":178,"end":185},"obj":"JJ"},{"id":"T7461","span":{"begin":185,"end":186},"obj":"."}],"relations":[{"id":"R6520","pred":"nsubjpass","subj":"T7430","obj":"T7434"},{"id":"R6521","pred":"prep","subj":"T7431","obj":"T7430"},{"id":"R6522","pred":"pobj","subj":"T7432","obj":"T7431"},{"id":"R6523","pred":"auxpass","subj":"T7433","obj":"T7434"},{"id":"R6524","pred":"ROOT","subj":"T7434","obj":"T7434"},{"id":"R6525","pred":"prep","subj":"T7435","obj":"T7434"},{"id":"R6526","pred":"det","subj":"T7436","obj":"T7437"},{"id":"R6527","pred":"pobj","subj":"T7437","obj":"T7435"},{"id":"R6528","pred":"prep","subj":"T7438","obj":"T7437"},{"id":"R6529","pred":"compound","subj":"T7439","obj":"T7440"},{"id":"R6530","pred":"pobj","subj":"T7440","obj":"T7438"},{"id":"R6531","pred":"cc","subj":"T7441","obj":"T7434"},{"id":"R6532","pred":"det","subj":"T7442","obj":"T7444"},{"id":"R6533","pred":"amod","subj":"T7443","obj":"T7444"},{"id":"R6534","pred":"nsubj","subj":"T7444","obj":"T7458"},{"id":"R6535","pred":"prep","subj":"T7445","obj":"T7444"},{"id":"R6536","pred":"det","subj":"T7446","obj":"T7447"},{"id":"R6537","pred":"pobj","subj":"T7447","obj":"T7445"},{"id":"R6538","pred":"cc","subj":"T7448","obj":"T7447"},{"id":"R6539","pred":"poss","subj":"T7449","obj":"T7450"},{"id":"R6540","pred":"conj","subj":"T7450","obj":"T7444"},{"id":"R6541","pred":"prep","subj":"T7451","obj":"T7450"},{"id":"R6542","pred":"det","subj":"T7452","obj":"T7453"},{"id":"R6543","pred":"pobj","subj":"T7453","obj":"T7451"},{"id":"R6544","pred":"prep","subj":"T7454","obj":"T7453"},{"id":"R6545","pred":"amod","subj":"T7455","obj":"T7457"},{"id":"R6546","pred":"amod","subj":"T7456","obj":"T7457"},{"id":"R6547","pred":"pobj","subj":"T7457","obj":"T7454"},{"id":"R6548","pred":"conj","subj":"T7458","obj":"T7434"},{"id":"R6549","pred":"advmod","subj":"T7459","obj":"T7458"},{"id":"R6550","pred":"acomp","subj":"T7460","obj":"T7458"},{"id":"R6551","pred":"punct","subj":"T7461","obj":"T7458"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}

{"project":"bionlp-st-ge-2016-coref","denotations":[{"id":"T7384","span":{"begin":102,"end":105},"obj":"Anaphor"},{"id":"T7385","span":{"begin":10,"end":15},"obj":"Antecedent"}],"relations":[{"id":"R6519","pred":"boundBy","subj":"T7384","obj":"T7385"}],"namespaces":[{"prefix":"_base","uri":"https://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}

{"project":"pmc-enju-pas","denotations":[{"id":"T6078","span":{"begin":0,"end":6},"obj":"NN"},{"id":"T6079","span":{"begin":7,"end":9},"obj":"IN"},{"id":"T6080","span":{"begin":10,"end":15},"obj":"NN"},{"id":"T6081","span":{"begin":16,"end":19},"obj":"VB"},{"id":"T6082","span":{"begin":20,"end":29},"obj":"VB"},{"id":"T6083","span":{"begin":30,"end":32},"obj":"IN"},{"id":"T6084","span":{"begin":33,"end":36},"obj":"DT"},{"id":"T6085","span":{"begin":37,"end":41},"obj":"NN"},{"id":"T6086","span":{"begin":42,"end":44},"obj":"IN"},{"id":"T6087","span":{"begin":45,"end":47},"obj":"NN"},{"id":"T6088","span":{"begin":48,"end":56},"obj":"NN"},{"id":"T6089","span":{"begin":57,"end":60},"obj":"CC"},{"id":"T6090","span":{"begin":61,"end":64},"obj":"DT"},{"id":"T6091","span":{"begin":65,"end":73},"obj":"JJ"},{"id":"T6092","span":{"begin":74,"end":80},"obj":"NN"},{"id":"T6093","span":{"begin":81,"end":83},"obj":"IN"},{"id":"T6094","span":{"begin":84,"end":88},"obj":"DT"},{"id":"T6095","span":{"begin":89,"end":97},"obj":"NN"},{"id":"T6096","span":{"begin":98,"end":101},"obj":"CC"},{"id":"T6097","span":{"begin":102,"end":105},"obj":"PRP-DOLLAR-"},{"id":"T6098","span":{"begin":106,"end":116},"obj":"NN"},{"id":"T6099","span":{"begin":117,"end":119},"obj":"IN"},{"id":"T6100","span":{"begin":120,"end":123},"obj":"DT"},{"id":"T6101","span":{"begin":124,"end":131},"obj":"NN"},{"id":"T6102","span":{"begin":132,"end":134},"obj":"IN"},{"id":"T6103","span":{"begin":135,"end":143},"obj":"VB"},{"id":"T6104","span":{"begin":144,"end":156},"obj":"JJ"},{"id":"T6105","span":{"begin":157,"end":167},"obj":"NN"},{"id":"T6106","span":{"begin":168,"end":171},"obj":"VB"},{"id":"T6107","span":{"begin":172,"end":177},"obj":"RB"},{"id":"T6108","span":{"begin":178,"end":185},"obj":"JJ"}],"relations":[{"id":"R5169","pred":"arg1Of","subj":"T6078","obj":"T6079"},{"id":"R5170","pred":"arg1Of","subj":"T6078","obj":"T6081"},{"id":"R5171","pred":"arg2Of","subj":"T6078","obj":"T6082"},{"id":"R5172","pred":"arg2Of","subj":"T6080","obj":"T6079"},{"id":"R5173","pred":"arg2Of","subj":"T6082","obj":"T6081"},{"id":"R5174","pred":"arg1Of","subj":"T6082","obj":"T6083"},{"id":"R5175","pred":"arg1Of","subj":"T6082","obj":"T6089"},{"id":"R5176","pred":"arg2Of","subj":"T6085","obj":"T6083"},{"id":"R5177","pred":"arg1Of","subj":"T6085","obj":"T6084"},{"id":"R5178","pred":"arg1Of","subj":"T6085","obj":"T6086"},{"id":"R5179","pred":"arg2Of","subj":"T6088","obj":"T6086"},{"id":"R5180","pred":"arg1Of","subj":"T6088","obj":"T6087"},{"id":"R5181","pred":"arg1Of","subj":"T6092","obj":"T6090"},{"id":"R5182","pred":"arg1Of","subj":"T6092","obj":"T6091"},{"id":"R5183","pred":"arg1Of","subj":"T6092","obj":"T6093"},{"id":"R5184","pred":"arg1Of","subj":"T6092","obj":"T6099"},{"id":"R5185","pred":"arg1Of","subj":"T6092","obj":"T6106"},{"id":"R5186","pred":"arg1Of","subj":"T6092","obj":"T6108"},{"id":"R5187","pred":"arg1Of","subj":"T6095","obj":"T6094"},{"id":"R5188","pred":"arg1Of","subj":"T6095","obj":"T6096"},{"id":"R5189","pred":"arg2Of","subj":"T6096","obj":"T6093"},{"id":"R5190","pred":"arg2Of","subj":"T6098","obj":"T6096"},{"id":"R5191","pred":"arg1Of","subj":"T6098","obj":"T6097"},{"id":"R5192","pred":"arg2Of","subj":"T6101","obj":"T6099"},{"id":"R5193","pred":"arg1Of","subj":"T6101","obj":"T6100"},{"id":"R5194","pred":"arg1Of","subj":"T6101","obj":"T6102"},{"id":"R5195","pred":"arg2Of","subj":"T6105","obj":"T6102"},{"id":"R5196","pred":"arg2Of","subj":"T6105","obj":"T6103"},{"id":"R5197","pred":"arg1Of","subj":"T6105","obj":"T6104"},{"id":"R5198","pred":"arg2Of","subj":"T6106","obj":"T6089"},{"id":"R5199","pred":"arg1Of","subj":"T6106","obj":"T6107"},{"id":"R5200","pred":"arg2Of","subj":"T6108","obj":"T6106"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}

{"project":"sentences","denotations":[{"id":"T6037","span":{"begin":0,"end":186},"obj":"Sentence"},{"id":"T124","span":{"begin":0,"end":186},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Levels of IL-1β are increased in the BALF of CF patients but the cellular source of this cytokine and its production in the context of targeted inflammasome activation are still unclear."}